Gcore Enhances Everywhere Inference With Flexible Deployment Options, Including Cloud, On-Premise, and Hybrid
16.1.2025 10:01:00 CET | Business Wire | Press release
Gcore, the global edge AI, cloud, network, and security solutions provider, today announced a major update to Everywhere Inference, formerly known as Inference at the Edge. This update offers greater flexibility in AI inference deployments, delivering ultra-low latency experiences for AI applications. Everywhere Inference now supports multiple deployment options including on-premise, Gcore's cloud, public clouds, or a hybrid mix of these environments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250116487759/en/

Everywhere Inference leverages Gcore’s extensive global network of over 180 points of presence, enabling real-time processing, instant deployment, and seamless performance across the globe (Graphic: Business Wire)
Gcore developed this update to its inference solution to address changing customer needs. With AI inference workloads growing rapidly, Gcore aims to empower businesses with flexible deployment options tailored to their individual requirements. Everywhere Inference leverages Gcore’s extensive global network of over 180 points of presence, enabling real-time processing, instant deployment, and seamless performance across the globe. Businesses can now deploy AI inference workloads across diverse environments while ensuring ultra-low latency by processing workloads closer to end users. It also enhances cost management and simplifies regulatory compliance across regions, offering a comprehensive and adaptable approach to modern AI challenges.
Seva Vayner, Product Director of Edge Cloud and Edge AI at Gcore, commented: “The update to Everywhere Inference marks a significant milestone in our commitment to enhancing the AI inference experience and addressing evolving customer needs. The flexibility and scalability of Everywhere Inference make it an ideal solution for businesses of all sizes, from startups to large enterprises.”
The new update enhances deployment flexibility by introducing smart routing, which automatically directs workloads to the nearest available compute resource. Additionally, Everywhere Inference now offers multi-tenancy for AI workloads, leveraging Gcore’s unique multi-tenancy capabilities to run multiple inference tasks simultaneously on existing infrastructure. This approach optimizes resource utilization for greater efficiency.
These new features address common challenges faced by businesses deploying AI inference. Balancing multiple cloud providers and on-premises systems for operations and compliance can be complex. The introduction of smart routing enables users to direct workloads to their preferred region, helping them stay compliant with local data regulations and industry standards. Data security is another key concern and with Gcore’s new flexible deployment options, businesses can securely isolate sensitive information on-premise, enhancing data protection.
Learn more at https://gcore.com/everywhere-inference.
About Gcore
Gcore is a global edge AI, cloud, network, and security solutions provider. Headquartered in Luxembourg, with a team of 600 operating from ten offices worldwide, Gcore provides solutions to global leaders in numerous industries. Gcore manages its global IT infrastructure across six continents, with one of the best network performances in Europe, Africa, and LATAM due to the average response time of 30 ms worldwide. Gcore’s network consists of 180 points of presence worldwide in reliable Tier IV and Tier III data centers, with a total network capacity exceeding 200 Tbps. Learn more at gcore.com and follow them on LinkedIn, Twitter, and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250116487759/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom